Osteoporosis drug industrySee also what's at your library, or elsewhere.
Broader term:Narrower term: |
Filed under: Osteoporosis drug industry -- United States
Items below (if any) are from related and broader terms.
Filed under: Pharmaceutical industry
Filed under: Pharmaceutical industry -- Developing countries -- Cost controlFiled under: Pharmaceutical industry -- Great BritainFiled under: Pharmaceutical industry -- Periodicals
Filed under: Pharmaceutical industry -- Technological innovations -- United States- Patent-Term Extension and the Pharmaceutical Industry (OTA-CIT-143; 1981), by United States Congress Office of Technology Assessment
Filed under: Pharmaceutical industry -- United States- Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
- Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
- Threescore Years and Ten: A Narrative of the First Seventy Years of Eli Lilly and Company, 1876-1946 (Chicago: Lakeside Press, 1946), by Roscoe Collins Clark (page images at HathiTrust)
Filed under: Narcotic laws -- United States -- HistoryFiled under: Drug legalization -- United StatesFiled under: Trials (Narcotic laws) -- United StatesFiled under: Patent medicines -- Law and legislation -- United StatesFiled under: Drugs -- Labeling -- Law and legislation -- United StatesFiled under: Drugs, Nonprescription -- Law and legislation
Filed under: Patent medicines -- Law and legislation -- Developing countries
Filed under: Drugs -- Labeling -- Law and legislation -- Developing countries
Filed under: Pharmacy -- Law and legislation -- Great Britain |